Nanoform Finland Plc - Asset Resilience Ratio

Latest as of March 2025: 55.62%

Nanoform Finland Plc (NANOFH) has an Asset Resilience Ratio of 55.62% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Nanoform Finland Plc for a breakdown of total debt and financial obligations.

Liquid Assets

€37.02 Million

≈ $43.28 Million USD Cash + Short-term Investments

Total Assets

€66.57 Million

≈ $77.82 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Nanoform Finland Plc's Asset Resilience Ratio has changed over time. See NANOFH free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Nanoform Finland Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Nanoform Finland Plc (NANOFH) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€32.68 Million	49.09%
Short-term Investments	€4.34 Million	6.52%
Total Liquid Assets	€37.02 Million	55.62%

Asset Resilience Insights

Very High Liquidity: Nanoform Finland Plc maintains exceptional liquid asset reserves at 55.62% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nanoform Finland Plc Industry Peers by Asset Resilience Ratio

Compare Nanoform Finland Plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	4.91%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Seegene Inc KQ:096530	Biotechnology	24.96%

Annual Asset Resilience Ratio for Nanoform Finland Plc (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Nanoform Finland Plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	57.73%	€41.45 Million ≈ $48.46 Million	€71.81 Million ≈ $83.95 Million	-3.05pp
2023-12-31	60.78%	€47.49 Million ≈ $55.52 Million	€78.13 Million ≈ $91.35 Million	-7.23pp
2022-12-31	68.02%	€68.45 Million ≈ $80.03 Million	€100.64 Million ≈ $117.66 Million	-7.92pp
2021-12-31	75.94%	€75.45 Million ≈ $88.21 Million	€99.35 Million ≈ $116.15 Million	-6.26pp
2020-12-31	82.19%	€60.73 Million ≈ $71.00 Million	€73.89 Million ≈ $86.38 Million	--

pp = percentage points

About Nanoform Finland Plc

HE:NANOFH Finland Biotechnology

Market Cap

$77.32 Million

€66.14 Million EUR

Market Cap Rank

#20263 Global

#95 in Finland

Share Price

€0.77

Change (1 day)

+0.00%

52-Week Range

€0.42 - €1.23

All Time High

€8.50